|Chennai||Rs. 24470.00 (1.37%)|
|Mumbai||Rs. 24900.00 (0.97%)|
|Delhi||Rs. 24200.00 (1.26%)|
|Kolkata||Rs. 24160.00 (0%)|
|Kerala||Rs. 24000.00 (0.63%)|
|Bangalore||Rs. 23800.00 (0%)|
|Hyderabad||Rs. 24140.00 (1.17%)|
Reuters Market Eye - Shares of Indoco Remedies Ltd
This is a significant positive for the company as the sale of products from these plants should contribute 30 percent of Indoco's FY16 operating profit, brokerage Religare said in a report on Monday.
"We expect the stock's discounted multiples (vs. peers) to narrow on strong EPS growth (45% CAGR over FY14-FY17E) and improving return ratios," the note said.
(Reporting by Abhishek Vishnoi)